Affinity proteins and their generation

Journal of Chemical Technology and Biotechnology

Volumn 88, Issue 1, 2013, Pages 25-38

  Ståhl, Stefan ^a   Kronqvist, Nina ^b   Jonsson, Andreas ^a   Löfblom, John ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Affinity proteins; Cell surface display; Combinatorial library; Directed evolution; Phage display; Protein engineering; Scaffold proteins; Selection systems

Indexed keywords

BIOCHEMICAL ENGINEERING; CELL MEMBRANES; GENETIC ENGINEERING; SCAFFOLDS (BIOLOGY);

CELL SURFACE DISPLAYS; COMBINATORIAL LIBRARY; DIRECTED EVOLUTION; PHAGE DISPLAY; PROTEIN ENGINEERING; SCAFFOLD PROTEIN; SELECTION SYSTEMS;

ANTIBODIES;

ANKYRIN; APOLIPOPROTEIN A1; CAPSID PROTEIN; COAT PROTEIN; DNA FRAGMENT; DNA POLYMERASE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GROWTH HORMONE; IMMUNOGLOBULIN; LIPOCALIN; MONOCLONAL ANTIBODY; MUTANT PROTEIN; OLIGONUCLEOTIDE; PEGDINETANIB; POLYCLONAL ANTIBODY; PROTEIN; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; SCAFFOLD PROTEIN; STAPHYLOCOCCUS PROTEIN A; TAQ POLYMERASE;

ANTIGEN BINDING; BACTERIOPHAGE M13; BINDING AFFINITY; BREAST CANCER; CANCER PATIENT; CELL SURFACE; CELL SURVIVAL; COMBINATORIAL LIBRARY; COMPLEMENTARITY DETERMINING REGION; DISULFIDE BOND; DNA SHUFFLING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXON SHUFFLING; FLOW CYTOMETRY; FUNGAL STRAIN; GENE LIBRARY; GENE SEQUENCE; HUMAN; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR RECOGNITION; NONHUMAN; PHAGE DISPLAY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS CARNOSUS; STAPHYLOCOCCUS XYLOSUS; SURFACE PROPERTY;

EID: 84870851878     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.3929     Document Type: Review

References (173)

1. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA and Arnheim N, Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (NY) 230:1350-1354 (1985).
2. Hutchison CA 3rd, Phillips S, Edgell MH, Gillam S, Jahnke P and Smith M, Mutagenesis at a specific position in a DNA sequence. J Biol Chem 253:6551-6560 (1978).
3. Winter G, Fersht AR, Wilkinson AJ, Zoller M and Smith M, Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding. Nature 299:756-758 (1982).
4. Bloom JD, Meyer MM, Meinhold P, Otey CR, MacMillan D and Arnold FH, Evolving strategies for enzyme engineering. Curr Opin Struct Biol 15:447-452 (2005).
5. Lippow SM and Tidor B, Progress in computational protein design. Curr Opin Biotechnol 18:305-311 (2007).
6. Cunningham BC and Wells JA, High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science (NY) 244:1081-1085 (1989).
7. Holliger P and Hudson PJ, Engineered antibody fragments and the rise of single domains. Nature Biotechnol 23:1126-1136 (2005).
8. Lofblom J, Frejd FY and Stahl S, Non-immunoglobulin based protein scaffolds. Curr Opin Biotechnol 22:843-848 (2011).
9. Gelderman KA, Tomlinson S, Ross GD and Gorter A, Complement function in mAb-mediated cancer immunotherapy. Trends Immunol 25:158-164 (2004).
10. Ward ES and Ghetie V, The effector functions of immunoglobulins: implications for therapy. Therapeut Immunol 2:77-94 (1995).
11. Goldsby RA, Kindt TJ, Osborne BA and Kuby J, Immunology, 5th edn. WH Freeman and Company, New York (2003).
12. Köhler G and Milstein C, Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497 (1975).
13. Jones PT, Dear PH, Foote J, Neuberger MS and Winter G, Replacing the complementarity - determining regions in a human antibody with those from a mouse. Nature 321:522-525 (1986).
14. Lonberg N, Human monoclonal antibodies from transgenic mice. In Handbook of Experimental Pharmacology, 69-97 (2008).
15. Lonberg N, Taylor LD, Harding FA, Trounstine M, Higgins KM, Schramm SR, Kuo CC, Mashayekh R, Wymore K, McCabe JG, et al, Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368:856-859 (1994).
16. Adams GP and Weiner LM, Monoclonal antibody therapy of cancer. Nature Biotechnol 23:1147-1157 (2005).
17. Wu AM and Senter PD, Arming antibodies: prospects and challenges for immunoconjugates. Nature biotechnol 23:1137-1146 (2005).
18. Graff CP and Wittrup KD, Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. Cancer Res 63:1288-1296 (2003).
19. Ghetie V and Ward ES, FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol Today 18:592-598 (1997).
20. Malmberg J, Sandstrom M, Wester K, Tolmachev V and Orlova A, Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibody. Nucl Med Biol 38:1093-1102 (2011).
21. Jefferis R, Antibody therapeutics: isotype and glycoform selection. Expert Opin Biol Therapy 7:1401-1413 (2007).
22. Porter RR, The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J 73:119-126 (1959).
23. McCafferty J, Griffiths AD, Winter G and Chiswell DJ, Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554 (1990).
24. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS and Whitlow M, Single-chain antigen-binding proteins. Science (NY) 242:423-426 (1988).
25. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R, et al, Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Nat Acad Sci USA 85:5879-5883 (1988).
26. Holt LJ, Herring C, Jespers LS, Woolven BP and Tomlinson IM, Domain antibodies: proteins for therapy. Trends Biotechnol 21:484-490 (2003).
27. Colby DW, Chu Y, Cassady JP, Duennwald M, Zazulak H, Webster JM, Messer A, Lindquist S, Ingram VM and Wittrup KD, Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Proc Nat Acad Sci USA 101:17616-17621 (2004).
28. Jespers L, Schon O, James LC, Veprintsev D and Winter G, Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. J Mol Biol 337:893-903 (2004).
29. Streltsov VA, Carmichael JA and Nuttall SD, Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype. Protein Sci 14:2901-2909 (2005).
30. Harmsen MM and De Haard HJ, Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77:13-22 (2007).
31. Nygren PA and Skerra A, Binding proteins from alternative scaffolds. J Immunol Methods 290:3-28 (2004).
32. Binz HK, Amstutz P and Pluckthun A, Engineering novel binding proteins from nonimmunoglobulin domains. Nature Biotechnol 23:1257-1268 (2005).
33. Hosse RJ, Rothe A and Power BE, A new generation of protein display scaffolds for molecular recognition. Protein Sci 15:14-27 (2006).
34. Skerra A, Alternative non-antibody scaffolds for molecular recognition. Curr Opin Biotechnol 18:295-304 (2007).
35. Gebauer M and Skerra A, Engineered protein scaffolds as next-generation antibody therapeutics. Curr Opin Chem Biol 13:245-255 (2009).
36. Ebersbach H, Fiedler E, Scheuermann T, Fiedler M, Stubbs MT, Reimann C, Proetzel G, Rudolph R and Fiedler U, Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein. J Mol Biol 372:172-185 (2007).
37. Silverman J, Liu Q, Bakker A, To W, Duguay A, Alba BM, Smith R, Rivas A, Li P, Le H, Whitehorn E, Moore KW, Swimmer C, Perlroth V, Vogt M, Kolkman J and Stemmer WP, Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains. Nature Biotechnol 23:1556-1561 (2005).
38. Kolmar H, Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins. Curr Opin Pharmacol 9:608-614 (2009).
39. Bertschinger J, Grabulovski D and Neri D, Selection of single domain binding proteins by covalent DNA display. Protein Eng Design Selection 20:57-68 (2007).
40. Lehmann A, Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery. Expert Opin Biol Ther 8:1187-1199 (2008).
41. Koide A, Bailey CW, Huang X and Koide S, The fibronectin type III domain as a scaffold for novel binding proteins. J Mol Biol 284:1141-1151 (1998).
42. Xu L, Aha P, Gu K, Kuimelis RG, Kurz M, Lam T, Lim AC, Liu H, Lohse PA, Sun L, Weng S, Wagner RW and Lipovsek D, Directed evolution of high-affinity antibody mimics using mRNA display. Chem Biol 9:933-942 (2002).
43. Lipovsek D, Lippow SM, Hackel BJ, Gregson MW, Cheng P, Kapila A and Wittrup KD, Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies. J Mol Biol 368:1024-1041 (2007).
44. Lipovsek D, Adnectins: engineered target-binding protein therapeutics. Protein Eng Design Selection 24:3-9 (2011).
45. Beste G, Schmidt FS, Stibora T and Skerra A, Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. Proc Nat Acad Sci USA 96:1898-1903 (1999).
46. Skerra A, Lipocalins as a scaffold. Biochim Biophys Acta 1482:337-350 (2000).
47. Skerra A, Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities. FEBS J 275:2677-2683 (2008).
48. Schlehuber S and Skerra A, Lipocalins in drug discovery: from natural ligand-binding proteins to 'anticalins'. Drug Discovery Today 10:23-33 (2005).
49. Boersma YL and Pluckthun A, DARPins and other repeat protein scaffolds: advances in engineering and applications. Curr Opin Biotechnol 22:849-857 (2011).
50. Lofblom J, Feldwisch J, Tolmachev V, Carlsson J, Stahl S and Frejd FY, Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett 584:2670-2680 (2010).
51. Forrer P, Stumpp MT, Binz HK and Pluckthun A, A novel strategy to design binding molecules harnessing the modular nature of repeat proteins. FEBS Lett 539:2-6 (2003).
52. Steiner D, Forrer P, Stumpp MT and Pluckthun A, Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display. Nature Biotechnol 24:823-831 (2006).
53. Moks T, Abrahmsen L, Nilsson B, Hellman U, Sjoquist J and Uhlen M, Staphylococcal protein A consists of five IgG-binding domains. Eur J Biochem/FEBS 156:637-643 (1986).
54. Ståhl S and Nygren PA, The use of gene fusions to protein A and protein G in immunology and biotechnology. Pathologie - Biologie 45:66-76 (1997).
55. Hober S, Nord K and Linhult M, Protein A chromatography for antibody purification. J Chromatog 848:40-47 (2007).
56. Nilsson B, Moks T, Jansson B, Abrahmsen L, Elmblad A, Holmgren E, Henrichson C, Jones TA and Uhlen M, A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng 1:107-113 (1987).
57. Jendeberg L, Persson B, Andersson R, Karlsson R, Uhlen M and Nilsson B, Kinetic analysis of the interaction between protein A domain variants and human Fc using plasmon resonance detection. J Mol Recognition 8:270-278 (1995).
58. Jansson B, Uhlen M and Nygren PA, All individual domains of staphylococcal protein A show Fab binding. FEMS Immunol Med Microbiol 20:69-78 (1998).
59. Engfeldt T, Renberg B, Brumer H, Nygren PA and Karlstrom AE, Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein. Chem Biochem 6:1043-1050 (2005).
60. Nord K, Gunneriusson E, Ringdahl J, Stahl S, Uhlen M and Nygren PA, Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain. Nature Biotechnol 15:772-777 (1997).
61. Grönwall C, Jonsson A, Lindström S, Gunneriusson E, Ståhl S and Herne N, Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides. J Biotechnol 128:162-183 (2007).
62. Friedman M, Nordberg E, Hoiden-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J and Stahl S, Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. Protein Eng Design Selection 20:189-199 (2007).
63. Wikman M, Steffen AC, Gunneriusson E, Tolmachev V, Adams GP, Carlsson J and Stahl S, Selection and characterization of HER2/neu-binding affibody ligands. Protein Eng Design Selection 17:455-462 (2004).
64. Kronqvist N, Malm M, Gostring L, Gunneriusson E, Nilsson M, Hoiden Guthenberg I, Gedda L, Frejd FY, Stahl S and Lofblom J, Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules. Protein Eng Design Selection 24:385-396 (2011).
65. Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Hoiden-Guthenberg I, Widstrom C, Carlsson J, Tolmachev V, Stahl S and Nilsson FY, Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 66:4339-4348 (2006).
66. Tolmachev V, Orlova A, Nilsson FY, Feldwisch J, Wennborg A and Abrahmsén L, Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy. Expert Opin Biol Ther 7:555-568 (2007).
67. Baum RP, Prasad V, Muller D, Schuchardt C, Orlova A, Wennborg A, Tolmachev V and Feldwisch J, Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. J Nucl Med 51:892-897 (2010).
68. McCullum EO, Williams BA, Zhang J and Chaput JC, Random mutagenesis by error-prone PCR. Methods Mol Biol 634:103-109 (2010).
69. Tindall KR and Kunkel TA, Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry 27:6008-6013 (1988).
70. Cirino PC, Mayer KM and Umeno D, Generating mutant libraries using error-prone PCR. Methods Mol Biol (Clifton, NJ) 231:3-9 (2003).
71. Cadwell RC and Joyce GF, Mutagenic PCR. PCR Methods Applic 3:S136-140 (1994).
72. Rowe LA, Geddie ML, Alexander OB and Matsumura I, A comparison of directed evolution approaches using the beta-glucuronidase model system. J Mol Biol 332:851-860 (2003).
73. Neylon C, Chemical and biochemical strategies for the randomization of protein encoding DNA sequences: library construction methods for directed evolution. Nucleic Acids Res 32:1448-1459 (2004).
74. Nguyen AW and Daugherty PS, Production of randomly mutated plasmid libraries using mutator strains. Methods Mol Biol (Clifton, NJ) 231:39-44 (2003).
75. Arunachalam TS, Wichert C, Appel B and Muller S, Mixed oligonucleotides for random mutagenesis: best way of making them. Org Biomol Chem 10:4641-4650 (2012).
76. Sondek J and Shortle D, A general strategy for random insertion and substitution mutagenesis: substoichiometric coupling of trinucleotide phosphoramidites. Proc Nat Acad Sci USA 89:3581-3585 (1992).
77. Virnekäs B, Ge L, Pluckthun A, Schneider KC, Wellnhofer G and Moroney SE, Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res 22:5600-5607 (1994).
78. Yanez J, Arguello M, Osuna J, Soberon X and Gaytan P, Combinatorial codon-based amino acid substitutions. Nucleic Acids Res 32:e158 (2004).
79. Kayushin A, Korosteleva M and Miroshnikov A, Large-scale solid-phase preparation of 3'-unprotected trinucleotide phosphotriesters- precursors for synthesis of trinucleotide phosphoramidites. Nucleosides Nucleotides Nucleic Acids 19:1967-1976 (2000).
80. Van den Brulle J, Fischer M, Langmann T, Horn G, Waldmann T, Arnold S, Fuhrmann M, Schatz O, O'Connell T, O'Connell D, Auckenthaler A and Schwer H, A novel solid phase technology for high-throughput gene synthesis. Bio Techniques 45:340-343 (2008).
81. Lutz S and Patrick WM, Novel methods for directed evolution of enzymes: quality, not quantity. Curr Opin Biotechnol 15:291-297 (2004).
82. Stemmer WP, DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci USA 91:10747-10751 (1994).
83. Stemmer WP, Rapid evolution of a protein in vitro by DNA shuffling. Nature 370:389-391 (1994).
84. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD and Winter G, By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581-597 (1991).
85. Crameri A, Cwirla S and Stemmer WP, Construction and evolution of antibody-phage libraries by DNA shuffling. Nature Med 2:100-102 (1996).
86. Smith GP, Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (NY) 228:1315-1317 (1985).
87. Bass S, Greene R and Wells JA, Hormone phage: an enrichment method for variant proteins with altered binding properties. Proteins 8:309-314 (1990).
88. Barbas CF, 3rd, Kang AS, Lerner RA and Benkovic SJ, Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88:7978-7982 (1991).
89. Rader C and Barbas CF, Phage display of combinatorial antibody libraries. Curr Opin Biotechnol 8:503-508 (1997).
90. Bradbury AR and Marks JD, Antibodies from phage antibody libraries. J Immunol Methods 290:29-49 (2004).
91. Mikawa YG, Maruyama IN and Brenner S, Surface display of proteins on bacteriophage lambda heads. J Mol Biol 262:21-30 (1996).
92. Houshmand H, Froman G and Magnusson G, Use of bacteriophage T7 displayed peptides for determination of monoclonal antibody specificity and biosensor analysis of the binding reaction. Analyt Biochem 268:363-370 (1999).
93. Webster, Filamentous phage biology. In Phage Display: a Laboratory Manual, ed by Barbas CF III, Burton DR, Scott JK and Silverman GJ. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (2001).
94. Smith GP and Petrenko VA, Phage Display. Chem Rev 97:391-410 (1997).
95. Sblattero D and Bradbury A, Exploiting recombination in single bacteria to make large phage antibody libraries. Nature Biotechnol 18:75-80 (2000).
96. Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, Rem L, Frans N, Daukandt M, Pieters H, van Hegelsom R, Neer NC, Nastri HG, Rondon IJ, Leeds JA, Hufton SE, Huang L, Kashin I, Devlin M, Kuang G, Steukers M, Viswanathan M, Nixon AE, Sexton DJ, Hoogenboom HR and Ladner RC, Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nature Biotechnol 23:344-348 (2005).
97. Lofblom J, Bacterial display in combinatorial protein engineering. Biotechnol J 6:1115-1129 (2011).
98. Gai SA and Wittrup KD, Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol 17:467-473 (2007).
99. Daugherty PS, Protein engineering with bacterial display. Current Opin Struct Biol 17:474-480 (2007).
100. Kronqvist N, Lofblom J, Jonsson A, Wernerus H and Stahl S, A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry. Protein Eng Design Selection 21:247-255 (2008).
101. Kronqvist N, Malm M, Rockberg J, Hjelm B, Uhlen M, Stahl S and Lofblom J, Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies. Recent Patents Biotechnol 4:171-182 (2010).
102. Boder ET and Wittrup KD, Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553-557 (1997).
103. Wang Z, Kim GB, Woo JH, Liu YY, Mathias A, Stavrou S and Neville DM Jr, Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv. Bioconjugate Chem 18:947-955 (2007).
104. Weber KS, Donermeyer DL, Allen PM and Kranz DM, Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci USA 102:19033-19038 (2005).
105. Razai A, Garcia-Rodriguez C, Lou J, Geren IN, Forsyth CM, Robles Y, Tsai R, Smith TJ, Smith LA, Siegel RW, Feldhaus M and Marks JD, Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol 351:158-169 (2005).
106. van den Beucken T, Pieters H, Steukers M, van der Vaart M, Ladner RC, Hoogenboom HR and Hufton SE, Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries. FEBS Lett 546:288-294 (2003).
107. Jin M, Song G, Carman CV, Kim YS, Astrof NS, Shimaoka M, Wittrup DK and Springer TA, Directed evolution to probe protein allostery and integrin I domains of 200, 000-fold higher affinity. Proc Natl Acad Sci USA 103:5758-5763 (2006).
108. Buonpane RA, Churchill HR, Moza B, Sundberg EJ, Peterson ML, Schlievert PM and Kranz DM, Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nature Med 13:725-729 (2007).
109. Feldhaus MJ, Siegel RW, Opresko LK, Coleman JR, Feldhaus JM, Yeung YA, Cochran JR, Heinzelman P, Colby D, Swers J, Graff C, Wiley HS and Wittrup KD, Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nature Biotechnol 21:163-170 (2003).
110. Lee HW, Lee SH, Park KJ, Kim JS, Kwon MH and Kim YS, Construction and characterization of a pseudo-immune human antibody library using yeast surface display. Biochem Biophys Res Commun 346:896-903 (2006).
111. Weaver-Feldhaus JM, Lou J, Coleman JR, Siegel RW, Marks JD and Feldhaus MJ, Yeast mating for combinatorial Fab library generation and surface display. FEBS Lett 564:24-34 (2004).
112. Hackel BJ, Kapila A and Wittrup KD, Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling. J Mol Biol 381:1238-1252 (2008).
113. Bowerman NA, Crofts TS, Chlewicki L, Do P, Baker BM, Christopher Garcia K and Kranz DM, Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Mol Immunol 46:3000-3008 (2009).
114. Francisco JA, Campbell R, Iverson BL and Georgiou G, Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. Proc Natl Acad Sci USA 90:10444-10448 (1993).
115. Daugherty PS, Chen G, Olsen MJ, Iverson BL and Georgiou G, Antibody affinity maturation using bacterial surface display. Protein Eng 11:825-832 (1998).
116. Getz JA, Rice JJ and Daugherty PS, Protease-resistant peptide ligands from a knottin scaffold library. ACS Chem Biol (2011).
117. Rice JJ and Daugherty PS, Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides. Protein Eng Design Selection 21:435-442 (2008).
118. Rice JJ, Schohn A, Bessette PH, Boulware KT and Daugherty PS, Bacterial display using circularly permuted outer membrane protein OmpX yields high affinity peptide ligands. Protein Sci 15:825-836 (2006).
119. Harvey BR, Georgiou G, Hayhurst A, Jeong KJ, Iverson BL and Rogers GK, Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Natl Acad Sci USA 101:9193-9198 (2004).
120. Mazor Y, Van Blarcom T, Mabry R, Iverson BL and Georgiou G, Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nature Biotechnol 25:563-565 (2007).
121. Woese CR, Bacterial evolution. Microbiol Rev 51:221-271 (1987).
122. Saitou N and Nei M, The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425 (1987).
123. Götz F, Staphylococcus carnosus: a new host organism for gene cloning and protein production. Soc Appl Bacteriol Symposium Series 19:49S-53S (1990).
124. Rosenstein R, Nerz C, Biswas L, Resch A, Raddatz G, Schuster SC and Gotz F, Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol 75:811-822 (2009).
125. Dilsen S, Paul W, Sandgathe A, Tippe D, Freudl R, Thommes J, Kula MR, Takors R, Wandrey C and Weuster-Botz D, Fed-batch production of recombinant human calcitonin precursor fusion protein using Staphylococcus carnosus as an expression-secretion system. Appl Microbiol Biotechnol 54:361-369 (2000).
126. Hansson M, Samuelson P, Nguyen TN and Stahl S, General expression vectors for Staphylococcus carnosus enabled efficient production of the outer membrane protein A of Klebsiella pneumoniae. FEMS Microbiol Lett 210:263-270 (2002).
127. Wieland KP, Wieland B and Gotz F, A promoter-screening plasmid and xylose-inducible, glucose-repressible expression vectors for Staphylococcus carnosus. Gene 158:91-96 (1995).
128. Samuelson P, Hansson M, Ahlborg N, Andreoni C, Gotz F, Bachi T, Nguyen TN, Binz H, Uhlen M and Stahl S, Cell surface display of recombinant proteins on Staphylococcus carnosus. J Bacteriol 177:1470-1476 (1995).
129. Wernérus H, Lehtiö J, Samuelson P and Ståhl S, Engineering of staphylococcal surfaces for biotechnological applications. J Biotechnol 96:67-78 (2002).
130. Wernérus H and Ståhl S, Vector engineering to improve a staphylococcal surface display system. FEMS Microbiol Lett 212:47-54 (2002).
131. Götz F, Popp F, Korn E and Schleifer KH, Complete nucleotide sequence of the lipase gene from Staphylococcus hyicus cloned in Staphylococcus carnosus. Nucleic Acids Res 13:5895-5906 (1985).
132. Liebl W and Götz F, Studies on lipase directed export of Escherichia coli beta-lactamase in Staphylococcus carnosus. Mol Gen Genet 204:166-173 (1986).
133. Sjölander A, Nygren PA, Ståhl S, Berzins K, Uhlén M, Perlmann P and Andersson R, The serum albumin-binding region of streptococcal protein G: a bacterial fusion partner with carrier-related properties. J Immunol Methods 201:115-123 (1997).
134. Guss B, Uhlén M, Nilsson B, Lindberg M, Sjöquist J and Sjödahl J, Region X, the cell-wall-attachment part of staphylococcal protein A. Eur J Biochemy/FEBS 138:413-420 (1984).
135. Navarre WW and Schneewind O, Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63:174-229 (1999).
136. Ton-That H, Faull KF and Schneewind O, Anchor structure of staphylococcal surface proteins. A branched peptide that links the carboxyl terminus of proteins to the cell wall. J Biol Chem 272:22285-22292 (1997).
137. Liljeqvist S, Samuelson P, Hansson M, Nguyen TN, Binz H and Ståhl S, Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus. Appl Environ Microbiol 63:2481-2488 (1997).
138. Liljeqvist S and Ståhl S, Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73:1-33 (1999).
139. Nguyen TN, Hansson M, Ståhl S, Bachi T, Robert A, Domzig W, Binz H and Uhlén M, Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination. Gene 128:89-94 (1993).
140. Samuelson P, Wernérus H, Svedberg M and Ståhl S, Staphylococcal surface display of metal-binding polyhistidyl peptides. Appl Environ Microbiol 66:1243-1248 (2000).
141. Wernérus H, Lehtiö J, Teeri T, Nygren PA and Ståhl S, Generation of metal-binding staphylococci through surface display of combinatorially engineered cellulose-binding domains. Appl Environ Microbiol 67:4678-4684 (2001).
142. Gunneriusson E, Samuelson P, Ringdahl J, Grönlund H, Nygren PA and Ståhl S, Staphylococcal surface display of immunoglobulin A (IgA)- and IgE-specific in vitro-selected binding proteins (affibodies) based on Staphylococcus aureus protein A. Appl Environ Microbiol 65:4134-4140 (1999b).
143. Gunneriusson E, Samuelson P, Uhlén M, Nygren PA and Ståhl S, Surface display of a functional single-chain Fv antibody on staphylococci. J Bacteriol 178:1341-1346 (1996).
144. Lehtiö J, Wernérus H, Samuelson P, Teeri TT and Ståhl S, Directed immobilization of recombinant staphylococci on cotton fibers by functional display of a fungal cellulose-binding domain. FEMS Microbiol Lett 195:197-204 (2001).
145. Wernérus H, Samuelson P and Ståhl S, Fluorescence-activated cell sorting of specific affibody-displaying staphylococci. Appl Environ Microbiol 69:5328-5335 (2003).
146. Lofblom J, Wernerus H and Stahl S, Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display. FEMS Microbiol Lett 248:189-198 (2005).
147. Kronqvist N, Lofblom J, Severa D, Stahl S and Wernerus H, Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display. FEMS Microbiol Lett 278:128-136 (2008).
148. Lofblom J, Kronqvist N, Uhlen M, Stahl S and Wernerus H, Optimization of electroporation-mediated transformation: staphylococcus carnosus as model organism. J Appl Microbiol 102:736-747 (2007).
149. Lofblom J, Sandberg J, Wernerus H and Stahl S, Evaluation of staphylococcal cell surface display and flow cytometry for postselectional characterization of affinity proteins in combinatorial protein engineering applications. Appl Environ Microbiol 73:6714-6721 (2007).
150. Nilvebrant J, Alm T, Hober S and Lofblom J, Engineering bispecificity into a single albumin-binding domain. PLoS One 6: e25791 (2011).
151. Hjelm B, Fernandez CD, Lofblom J, Stahl S, Johannesson H, Rockberg J and Uhlen M, Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase. N Biotechnol 27:129-137 (2010).
152. Rockberg J, Lofblom J, Hjelm B, Stahl S and Uhlen M, Epitope mapping using gram-positive surface display. Curr Protocol Immunol 9:9 (2010).
153. Rockberg J, Lofblom J, Hjelm B, Uhlen M and Stahl S, Epitope mapping of antibodies using bacterial surface display. Nature Methods 5:1039-1045 (2008).
154. Mattheakis LC, Bhatt RR and Dower WJ, An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci USA 91:9022-9026 (1994).
155. Dreier B and Pluckthun A, Rapid selection of high-affinity binders using ribosome display. Methods Mol Biol 805:261-286 (2012).
156. Pluckthun A, Ribosome display: a perspective. Methods Mol Biol 805:3-28 (2012).
157. Hoogenboom HR, Selecting and screening recombinant antibody libraries. Nature Biotechnol 23:1105-1116 (2005).
158. Roberts RW, Totally in vitro protein selection using mRNA-protein fusions and ribosome display. Curr Opin Chem Biol 3:268-273 (1999).
159. Lipovsek D and Plückthun A, In-vitro protein evolution by ribosome display and mRNA display. J Immunol Methods 290:51-67 (2004).
160. Roberts RW and Szostak JW, RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci USA 94:12297-12302 (1997).
161. Michnick SW, Remy I, Campbell-Valois FX, Vallee-Belisle A and Pelletier JN, Detection of protein-protein interactions by protein fragment complementation strategies. Methods Enzymol 328:208-230 (2000).
162. Bruckner A, Polge C, Lentze N, Auerbach D and Schlattner U, Yeast two-hybrid, a powerful tool for systems biology. Int J Mol Sci 10:2763-2788 (2009).
163. Hu JC, Model systems: Studying molecular recognition using bacterial n-hybrid systems. Trends Microbiol 9:219-222 (2001).
164. Morell M, Ventura S and Aviles FX, Protein complementation assays: approaches for the in vivo analysis of protein interactions. FEBS Lett 583:1684-1691 (2009).
165. Pelletier JN, Campbell-Valois FX and Michnick SW, Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proc Natl Acad Sci USA 95:12141-12146 (1998).
166. Arndt KM, Pelletier JN, Muller KM, Alber T, Michnick SW and Pluckthun A, A heterodimeric coiled-coil peptide pair selected in vivo from a designed library-versus-library ensemble. J Mol Biol 295:627-639 (2000).
167. Galarneau A, Primeau M, Trudeau LE and Michnick SW, Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nature Biotechnol 20:619-622 (2002).
168. Wehrman T, Kleaveland B, Her JH, Balint RF and Blau HM, Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments. Proc Natl Acad Sci USA 99:3469-3474 (2002).
169. Koch H, Grafe N, Schiess R and Pluckthun A, Direct selection of antibodies from complex libraries with the protein fragment complementation assay. J Mol Biol 357:427-441 (2006).
170. Secco P, D'Agostini E, Marzari R, Licciulli M, Di Niro R, D'Angelo S, Bradbury AR, Dianzani U, Santoro C and Sblattero D, Antibody library selection by the {beta}-lactamase protein fragment complementation assay. Protein Eng Design Selection 22:149-158 (2009).
171. Lofdahl PA, Nord O, Janzon L and Nygren PA, Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay. N Biotechnol 26:251-259 (2009).
172. Lofdahl PA and Nygren PA, Affinity maturation of a TNFalpha-binding affibody molecule by Darwinian survival selection. Biotechnol Appl Biochem 55:111-120 (2010).
173. Wallberg H, Lofdahl PK, Tschapalda K, Uhlen M, Tolmachev V, Nygren PK and Stahl S, Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand. Protein Express Purif 76:127-135 (2011).